TL;DR:<p>&gt; Portions of the inspection report that CMS had initially redacted included references to the Edisons, Theranos’s family of proprietary blood-testing devices. Those passages, which are no longer redacted in the latest version, show that the devices often failed to meet Theranos’s own accuracy requirements for a range of tests, including one to detect prostate cancer.